Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Latrepirdine dihydrochloride by Bigespas for Dementia Associated With Alzheimer's Disease: Likelihood of Approval
Latrepirdine dihydrochloride is under clinical development by Bigespas and currently in Phase III for Dementia Associated With Alzheimer's Disease. According...